Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar

UPL’s arm enters into license agreement with Meiji Seika Pharma

11 May 2021

UPL’s subsidiary has entered into a license agreement with Japanese company, Meiji Seika Pharma for exclusive access to Flupyrimin for rice in Southeast Asia. Under the license agreement, UPL will obtain exclusive rights to develop, register and commercialize formulations of Flupyrimin for foliar applications in rice in Southeast Asia, expanding the on-going collaboration between the two companies with this compound. Together, both companies will continue their contributions to the development of differentiated solutions based on Flupyrimin to address farmer pain points and improve their livelihoods.

UPL is global player of crop protection products has customer base in 123 countries. It has subsidiary offices in Argentina, Australia, Bangladesh, Brazil, China, Canada, Denmark, Indonesia, France, Hong Kong, Japan, Korea, Mauritius, Mexico, New Zealand, Russia, Spain, Taiwan, South Africa, USA, UK, Vietnam and Zambia.

UPL Share Price

807.95 -26.45 (-3.17%) Jun 18, 18:03
1 Year Price Chart
Peers
Company Name CMP
UPL 807.95
BASF India 2641.35
Bayer CropScience 5577.30
PI Industries 2849.05
Rallis India 344.50
View more..
Sensex vs UPL
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback